Loading provider…
Loading provider…
Hematology & Oncology Physician in New Orleans, LA
NPI: 1083679468Primary Practice Location
TOURO INFIRMARY
1401 Foucher St, New Orleans, LA
Primary Employer
Ochsner Clinic LLC
ochsner.org
HQ Phone
Get MD Scott's Phone NumberMobile
Get MD Scott's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardLA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 147 | 190 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 110 | 262 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 33 | 86 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 28 | 38 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 28 | 107 |
Authors: Warren Alexander, Steven Kossman, Orlan Macdonald, Charles Bane, Savitha Balaraman, Todd Shenkenberg, Adil Akhtar, Vera Vavinskaya, Xingwei Sui, Jennifer Slim, Bruce Bank, Vlad Sandulache, Andrew Pippas, Karim Welaya, Steven Saccaro
Journal: J Cancer Res Clin Oncol
Publication Date: 2023-08-08
Lead Sponsor: Veru Inc.
Intervention / Treatment: DRUG: Sabizabulin, DRUG: Exemestane monotherapy, exemestane plus everolimus, or selective estrogen receptor modulator
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Letrozole, DRUG: Ribociclib, DRUG: Leuprolide, DRUG: Goserelin
Lead Sponsor: OSE Immunotherapeutics
Intervention / Treatment: DRUG: Docetaxel, DRUG: Pemetrexed, BIOLOGICAL: OSE2101